CANBAS CO., LTD. · 株式会社キャンバス

CanBas Co Ltd is a Japan-based company mainly engaged in pharmaceutical business. It is a drug discovery venture company engaged in basic research and clinical development of anticancer drugs. Its basic research on anticancer drugs includes examining drug discovery concepts, selecting drug candidate compounds using methods based on those concepts, simple animal testing, and collecting and analyzing basic data on anticancer drug candidate compounds that have already progressed to the development stage. It is engaged in early clinical development (preclinical trials and the first half of clinical trials conducted immediately before applying for clinical trial initiation) and late clinical development (the second half of clinical trials aimed at applying for new drug approval). Its development pipelines include CBP501, CBS9106, and follow-on pipelines such as CBT005, CBP-A08 and IDO/TDO inhibitor. Employees 14 Sector Pharmaceuticals Calendar Aug. 11 - Earnings release - Annual 2026